{"comparisonGroups":["Homo sapiens_Fibroblast_Drug Vehicle_HT01 wild type","Homo sapiens_Fibroblast_Nicotinamide Riboside_HT01 wild type"],"dateCreated":"2025-09-26 00:00:00","display_title":"Fibroblasts: Nicotinamide Riboside vs vehicle control","group_a_title":"Wild type fibroblasts treated with drug vehicle.. Provides baseline for comparison with treated wild type samples.","group_b_title":"Wild type fibroblasts treated with Nicotinamide Riboside.. Evaluates the effect of Nicotinamide Riboside on wild type fibroblasts.","id":"MTBLS1223_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS1223","studyUrl":"http://integmet.org/study/MTBLS1223","title":"Wild_Type_Control_vs_Treatment","topHits":[{"chebi_id":"18304","direction":"down","inn_name":"","iupac_name":"adenosine 5'-{3-[1-(3-carboxypyridinio)-1,4-anhydro-<small>D</small>-ribitol-5-yl] dihydrogen diphosphate}","metabolite_id":"SENPVEZBRZQVST-HISDBWNOSA-O","pvalue":0.003468158312426,"ratio":1e-06,"synonym_name":"Deamido-NAD+"}],"totalFeatures":4}